I consent to the use of cookies on this page for analyses, personalised content and advertising.

Proven Cost-effectiveness

Debrisoft can save you money.

Brackin (2018) compared Debrisoft to standard of care methods for debridement, analyzing their clinical and cost effectiveness. Wound size reduction, necrotic tissue, number of dressing changes during the trial period and supply and nursing costs were documented and evaluated.

Suprasorb G was applied as wound dressing to provide a moist wound healing environment.

Results show impressive improvement and cost reduction when using Debrisoft for cleansing and debridement.


Download case study    See NICE guidance  

Results

Table 1. Collagenase

Initial Size (cm) Size reduction Necrotic Tissue Reduction
3.0 x 4.8 39% 15%
9.0 x 6.2 +4% 0%
3.3 x 3.0 27% 20%
3.5 x 2.5 16% 50%
6.2 x 2.0 4% 28%
Supply/Nursing cost:
$1926
Average Size Reduction:
21%
Dressing changes in trial period:
SEVEN

Table 2. Medical honey

Initial Size (cm) Size reduction Necrotic Tissue Reduction
4.6 x 3.0 3% 28%
2.5 x 2.5 52% 52%
3.0 x 3.0 17% 48%
11.0 x 4.5 20% 100% (2.5cm2)
5.0 x 3.0 0% 20%
Supply/Nursing cost:
$448
Average Size Reduction:
18%
Dressing changes in trial period:
THREE

Table 3. Dynamic gel with MFD

Initial Size (cm) Size reduction Necrotic Tissue Reduction
3.5 x 2.0 83% 66%
3.7 x 1.0 100% 100% (1.85cm2)
3.0 x 3.0 79% 100% (4.5cm2)
22 x 5.0 43% N/A
2.0 x 1.5 82% 100% (1.5cm2)
Supply/Nursing cost:
$181
Average Size Reduction:
77%
Dressing changes in trial period:
ONE